Equities analysts expect Genpact Limited (NYSE:G) to report earnings per share (EPS) of $0.56 for the current quarter, Zacks reports. Five analysts have made estimates for Genpact’s earnings. The lowest EPS estimate is $0.54 and the highest is $0.57. Genpact reported earnings of $0.52 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 7.7%. The firm is scheduled to issue its next quarterly earnings report on Thursday, February 6th.

On average, analysts expect that Genpact will report full-year earnings of $2.04 per share for the current fiscal year, with EPS estimates ranging from $2.03 to $2.04. For the next fiscal year, analysts forecast that the company will report earnings of $2.28 per share, with EPS estimates ranging from $2.24 to $2.33. Zacks’ EPS calculations are an average based on a survey of research analysts that cover Genpact.

Genpact (NYSE:G) last posted its earnings results on Thursday, November 7th. The business services provider reported $0.56 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.52 by $0.04. The firm had revenue of $888.80 million during the quarter, compared to analysts’ expectations of $884.91 million. Genpact had a net margin of 8.84% and a return on equity of 21.42%. The company’s revenue was up 18.8% compared to the same quarter last year. During the same period in the previous year, the company earned $0.48 earnings per share.

Several equities research analysts recently issued reports on G shares. ValuEngine lowered shares of Genpact from a “buy” rating to a “hold” rating in a research note on Friday, September 27th. Needham & Company LLC reissued a “buy” rating and set a $48.00 target price on shares of Genpact in a research report on Friday, November 8th. Finally, Zacks Investment Research upgraded Genpact from a “sell” rating to a “hold” rating and set a $43.00 target price on the stock in a report on Thursday, September 12th. Six analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The stock currently has an average rating of “Hold” and a consensus price target of $40.18.

Shares of G traded up $0.15 during mid-day trading on Monday, hitting $40.66. 1,239,075 shares of the company’s stock were exchanged, compared to its average volume of 1,063,858. The stock has a market cap of $7.72 billion, a price-to-earnings ratio of 25.41, a P/E/G ratio of 2.14 and a beta of 0.79. The firm has a fifty day moving average of $39.75 and a two-hundred day moving average of $38.99. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.77. Genpact has a twelve month low of $25.48 and a twelve month high of $44.55.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Monday, December 9th will be issued a dividend of $0.085 per share. The ex-dividend date is Friday, December 6th. This represents a $0.34 annualized dividend and a yield of 0.84%. Genpact’s dividend payout ratio (DPR) is presently 21.25%.

In other news, Director David Humphrey sold 12,916,004 shares of the business’s stock in a transaction on Tuesday, November 26th. The shares were sold at an average price of $39.87, for a total value of $514,961,079.48. Following the completion of the sale, the director now directly owns 34,907 shares in the company, valued at $1,391,742.09. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Company insiders own 1.86% of the company’s stock.

Several large investors have recently modified their holdings of G. Marshall Wace LLP increased its stake in shares of Genpact by 33.5% in the second quarter. Marshall Wace LLP now owns 1,689,255 shares of the business services provider’s stock worth $64,344,000 after purchasing an additional 424,264 shares during the period. Calamos Advisors LLC boosted its stake in Genpact by 335.3% during the 2nd quarter. Calamos Advisors LLC now owns 58,020 shares of the business services provider’s stock valued at $2,210,000 after purchasing an additional 44,690 shares during the period. OLD National Bancorp IN boosted its stake in Genpact by 1.4% during the 3rd quarter. OLD National Bancorp IN now owns 36,775 shares of the business services provider’s stock valued at $1,425,000 after purchasing an additional 512 shares during the period. Johnson Financial Group Inc. bought a new stake in Genpact during the 2nd quarter valued at approximately $31,000. Finally, Atria Investments LLC grew its holdings in Genpact by 23.1% in the 2nd quarter. Atria Investments LLC now owns 14,552 shares of the business services provider’s stock valued at $581,000 after buying an additional 2,726 shares during the last quarter. 94.34% of the stock is currently owned by institutional investors.

Genpact Company Profile

Genpact Limited provides business process outsourcing and information technology (IT) services North and Latin America, India, rest of Asia, and Europe. Its finance and accounting services include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; enterprise performance management consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls.

See Also: What are the components of an earnings report?

Get a free copy of the Zacks research report on Genpact (G)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.